Avidity Partners Management’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,855,400
| Closed | -$4.68M | – | 87 |
|
|
2022
Q4 | $4.68M | Sell |
1,855,400
-604,600
| -25% | -$1.52M | 0.1% | 69 |
|
|
2022
Q3 | $4.48M | Hold |
2,460,000
| – | – | 0.09% | 81 |
|
|
2022
Q2 | $7.75M | Hold |
2,460,000
| – | – | 0.18% | 53 |
|
|
2022
Q1 | $15.2M | Hold |
2,460,000
| – | – | 0.32% | 56 |
|
|
2021
Q4 | $34.9M | Buy |
2,460,000
+10,000
| +0.4% | +$142K | 0.74% | 43 |
|
|
2021
Q3 | $19.6M | Sell |
2,450,000
-300,000
| -11% | -$2.4M | 0.43% | 52 |
|
|
2021
Q2 | $78.6M | Sell |
2,750,000
-90,000
| -3% | -$2.57M | 2.12% | 13 |
|
|
2021
Q1 | $82.5M | Buy |
2,840,000
+282,000
| +11% | +$8.19M | 2.28% | 10 |
|
|
2020
Q4 | $30.5M | Buy |
2,558,000
+470,200
| +23% | +$5.61M | 0.99% | 35 |
|
|
2020
Q3 | $14.4M | Buy |
+2,087,800
| New | +$14.4M | 0.67% | 39 |
|